Public and investor relations for the innovators in healthcare and technology

We’ve been delivering measurable PR and IR results for innovative companies in health and technology since our founding more than 30 years ago originally as Noonan/Russo Communications.  When it comes to raising awareness of your company and product as well as forging new relationships, no one connects you to the people you want to know like we do. Our team of PhD-level scientists, former journalists, TV producers, and Wall Street professionals is on a first-name basis with the who’s who in media, finance, medicine and technology.

FSD Pharma aims to have the world’s largest hydroponic indoor cannabis production and processing facility
| Proactive Investors

“HUGE” is the Canadian stock ticker for FSD Pharma Inc (CSE:HUGE) (OTCQB: FSDDF) (FRA:0K9) and it hints at the size of the company’s aspirations. Its aim? The development of high-quality, indoor-grown, pharmaceutical-grade cannabis. But it’s even more than that. The company intends to target all legal aspects of the cannabis industry: cultivation, processing, manufacturing, extracts […]

read more
Despite market uncertainty, healthcare CEOs of all stripes remain upbeat about 2019
| MedCity News

The market gyrations and the shutdown. The trade wars and global uncertainty. None of the above has squashed the sunny optimism that a group of healthcare CEOs demonstrated at a roundtable discussion during the annual J.P. Morgan Healthcare Conference in San Francisco last week.

read more
This Alzheimer’s Vaccine Just Might Work
| Bloomberg

For two decades, biotech companies trying to tackle Alzheimer’s disease have had little success. While vaccines have often shown promise for certain patients, they’ve come with devastating side effects for others—brain swelling, for example—because researchers haven’t been able to reliably keep patients’ immune systems from kicking into overdrive when exposed to the vaccines’ antibodies. That is until […]

read more